VaxGen Completes Merger With diaDexus
Under the terms of merger agreement, diaDexus expects to operate as a wholly-owned subsidiary of VaxGen. VaxGen has issued approximately 19,960,534 shares to certain diaDexus stockholders and officers,
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Methylphenidate is used to treat attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD), and narcolepsy. Tris Pharma claimed that this is the first-ever generic ANDA approved by
Upp Technology’s software selected from the suite includes IRMS|EM Emergency Management, IRMS|WM Warehouse Management and IRMS|BI Business Intelligence to provide the BSPS with real-time visibility, enhanced accuracy and